| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |